Bempedoic Acid

In this episode of Inside Cardiology, Practical Cardiology's Chief Advisory Board member Guy Mintz, MD, has a lengthy discussion with Steve Nissen, MD, of the Cleveland Clinic, related to bempedoic acid. A novel agent receiving approval in early 2020, bempedoic acid has the potential to help transform treatment algorithms for many lipidologists.

In the interview, Mintz has Nissen, who is also a principal investigator in the pivotal CLEAR program, dive deeper into the mechanism of action of bempedoic acid and where he believes it fits in the next set of guidelines on lipid management. Later in their discussion, Nissen offers insight into the highly-anticipated CLEAR Outcomes trial.